Gerd Hasenfuß Livres

In a variety of cardiac diseases the influence of heart rate on cardiac function is altered and both heart rate and heart rate variability are of great relevance for the prognosis of cardiac patients. This book provides a summary of the current knowledge on the influence of heart rate on myocardial function and hemodynamics in non-failing and failing animal and human hearts. The subcellular and molecular alterations underlying the altered heart rate response in heart failure are discussed in detail. In addition, studies related to the impact of heart rate and heart rate variability on arrhythmogenesis and prognosis in patients with cardiac diseases are critically reviewed. Finally, the relevance of heart rate control by therapeutic interventions is also discussed. The book contains 19 different chapters written by well-known experts in this novel and clinically important field.

This book provides an approach to discussing new targets for molecular strategies in heart failure therapy. On the basis of most recent data, international experts in this field elaborate on the most relevant pathophysiological alterations in heart failure on a molecular level and discuss potential strategies. These include technical aspects of gene transfer, gene transfer approaches to treating pump failure and arrhythmias, and gene transfer to prevent apoptosis. Furthermore, the topics myocyte transplantation and cell cycle regulation are discussed.The book contains twenty-one chapters including state-of-the-art review articles as well as original papers.

Alteration of excitation-contraction coupling in the failing human heart was deemed an interesting subject for a dialogue between basic scientists and clinical researchers in continuation of previous Gargellen Conferences concerned with the function of the normal and failing human myocardium. In 1987 basic mechanisms and clinical implications of then new insights into cardiac energetics was followed by a comprehensive review of inotropic stimulation and myocardial energetics in 1989. Here, we undertook a re-evaluation of the principles of inotropic stimulation and of its potential therapeutic value, based on new observa tions from experiments with human myocardium. In 1992 the risk due to myocardial phenotype change as a consequence of adaptation in heart failure was published. Here, alterations of subcellular structures and functions as a consequence of chronic heart failure, summarized as phenotype change, could be described as an essential characteristic of the failing human myocardium. This topic was discussed in greater depth in the volume „Cellular and Molecular Alterations in the Failing Human Heart“, considering both the sarcolemma and the phosphodiesterases, as well as excitation-contraction coupling and contractile proteins, extracellular matrix, and mitrochondrial function.

Diese Pocket-Leitlinie umfasst alles Wissenswerte zu Diagnose und Behandlung der akuten und chronischen Herzinsuffizienz: • Tabellen, Algorithmen und strukturierte Textabschnitte; • Farbliche Orientierung zu Empfehlungs- und Evidenzgrad; • Kommentare der DGK: Anpassung der ESC-Guidelines an die deutschen Erfordernisse; • Auflistung und Interpretation häufiger pathologischer Laborwerte bei Herzinsuffizienz; • Relevanz und Grenzwerte kardialer Biomarker; • Technische Untersuchungsmethoden bei Herzinsuffizienz; • Neueste Empfehlungen zur medikamentösen und invasiven Therapie. So bleibt keine Frage zur Herzinsuffizienz offen!